Cargando…
m(6)A methylation: a potential key player in understanding and treating COVID-2019 infection
Since its discovery in 2019, coronavirus disease 2019 (COVID-2019) spans a wide clinical spectrum from the asymptomatic stage, mild infection, to severe pneumonia. In patients with COVID-2019, factors such as advanced age, diabetes, or hypertension are associated with a significantly increased risk...
Autores principales: | Qian, Weiwei, Zhou, Jian, Duan, Ligeng, Wang, Haoyu, Xu, Shuyun, Cao, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439140/ https://www.ncbi.nlm.nih.gov/pubmed/37596265 http://dx.doi.org/10.1038/s41420-023-01580-1 |
Ejemplares similares
-
An overview of the effects and mechanisms of m6 A methylation on innate immune cells in sepsis
por: Qian, Weiwei, et al.
Publicado: (2022) -
Exploration of m(6)A methylation regulators as epigenetic targets for immunotherapy in advanced sepsis
por: Qian, Weiwei, et al.
Publicado: (2023) -
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
por: Shafqat, Areez, et al.
Publicado: (2022) -
ANXA6: a key molecular player in cancer progression and drug resistance
por: Cao, Jinlong, et al.
Publicado: (2023) -
ST6GAL1: A key player in cancer
por: Garnham, Rebecca, et al.
Publicado: (2019)